We have selected three new companies, Volumina Medical, Parithera and PeriVision, for the Biopôle Start-up Fund, the final recipients of 2022. The initiative, which includes up to CHF 90,000 of support per year for up to three consecutive years, aims to boost innovative and promising life sciences projects. The fund is designed to help with the costs of rental, R&D and key services.